- Home
- MHH vs MIST Comparison
MHH vs MIST Comparison
Compare MHH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | MIST |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 146.9M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MHH | MIST |
|---|---|---|
| Price | $7.18 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.86 |
| AVG Volume (30 Days) | 6.0K | ★ 1.4M |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $191,371,000.00 | N/A |
| Revenue This Year | N/A | $147.62 |
| Revenue Next Year | $5.86 | $476.43 |
| P/E Ratio | $721.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.51 | $0.75 |
| 52 Week High | $8.37 | $3.06 |
Technical Indicators
Market Signals| Indicator | MHH | MIST |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.29 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 46.38 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.